BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33498862)

  • 1. MINDIN Exerts Protumorigenic Actions on Primary Prostate Tumors via Downregulation of the Scaffold Protein NHERF-1.
    Álvarez-Carrión L; Gutiérrez-Rojas I; Rodríguez-Ramos MR; Ardura JA; Alonso V
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The secreted matrix protein mindin increases prostate tumor progression and tumor-bone crosstalk via ERK 1/2 regulation.
    Ardura JA; Gutiérrez-Rojas I; Álvarez-Carrión L; Rodríguez-Ramos MR; Pozuelo JM; Alonso V
    Carcinogenesis; 2019 Jul; 40(7):828-839. PubMed ID: 31168562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MINDIN secretion by prostate tumors induces premetastatic changes in bone via β-catenin.
    Ardura JA; Álvarez-Carrión L; Gutiérrez-Rojas I; Friedman PA; Gortázar AR; Alonso V
    Endocr Relat Cancer; 2020 Jul; 27(7):441-456. PubMed ID: 32357310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages.
    Cha HR; Lee JH; Hensel JA; Sawant AB; Davis BH; Lee CM; Deshane JS; Ponnazhagan S
    Prostate; 2016 May; 76(7):624-36. PubMed ID: 26856684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.
    Lee SJ; Ritter SL; Zhang H; Shim H; Hall RA; Yun CC
    Gastroenterology; 2011 Mar; 140(3):924-34. PubMed ID: 21134377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytic and neuronal localization of the scaffold protein Na+/H+ exchanger regulatory factor 2 (NHERF-2) in mouse brain.
    Paquet M; Kuwajima M; Yun CC; Smith Y; Hall RA
    J Comp Neurol; 2006 Feb; 494(5):752-62. PubMed ID: 16374813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mindin serves as a tumour suppressor gene during colon cancer progression through MAPK/ERK signalling pathway in mice.
    Cheng XS; Huo YN; Fan YY; Xiao CX; Ouyang XM; Liang LY; Lin Y; Wu JF; Ren JL; Guleng B
    J Cell Mol Med; 2020 Aug; 24(15):8391-8404. PubMed ID: 32614521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.
    Wang LF; Liu YS; Yang B; Li P; Cheng XS; Xiao CX; Liu JJ; Li S; Ren JL; Guleng B
    Oncogene; 2018 Feb; 37(5):601-615. PubMed ID: 28991232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. kappa Opioid receptor interacts with Na(+)/H(+)-exchanger regulatory factor-1/Ezrin-radixin-moesin-binding phosphoprotein-50 (NHERF-1/EBP50) to stimulate Na(+)/H(+) exchange independent of G(i)/G(o) proteins.
    Huang P; Steplock D; Weinman EJ; Hall RA; Ding Z; Li J; Wang Y; Liu-Chen LY
    J Biol Chem; 2004 Jun; 279(24):25002-9. PubMed ID: 15070904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
    Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.
    Parry R; Schneider D; Hudson D; Parkes D; Xuan JA; Newton A; Toy P; Lin R; Harkins R; Alicke B; Biroc S; Kretschmer PJ; Halks-Miller M; Klocker H; Zhu Y; Larsen B; Cobb RR; Bringmann P; Roth G; Lewis JS; Dinter H; Parry G
    Cancer Res; 2005 Sep; 65(18):8397-405. PubMed ID: 16166318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice.
    Williams TM; Hassan GS; Li J; Cohen AW; Medina F; Frank PG; Pestell RG; Di Vizio D; Loda M; Lisanti MP
    J Biol Chem; 2005 Jul; 280(26):25134-45. PubMed ID: 15802273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism.
    Li N; Qin J; Lan L; Zhang H; Liu F; Wu Z; Ni H; Wang Y
    Cancer Biol Ther; 2015; 16(2):297-306. PubMed ID: 25756512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.
    Dai JL; Wang L; Sahin AA; Broemeling LD; Schutte M; Pan Y
    Oncogene; 2004 Nov; 23(53):8681-7. PubMed ID: 15467753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
    Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
    Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NHERF-1: modulator of glioblastoma cell migration and invasion.
    Kislin KL; McDonough WS; Eschbacher JM; Armstrong BA; Berens ME
    Neoplasia; 2009 Apr; 11(4):377-87. PubMed ID: 19308292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice.
    Yang D; Holt GE; Velders MP; Kwon ED; Kast WM
    Cancer Res; 2001 Aug; 61(15):5857-60. PubMed ID: 11479226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
    Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
    Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic benefits of mindin as a prostate cancer biomarker: Dijagnostičke prednosti mindina kao biomarkera raka prostate.
    Hanousková L; Řezáč J; Veselý Š; Průša R; Kotaška K
    J Med Biochem; 2020 Jan; 39(1):108-111. PubMed ID: 32547325
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.